Exalenz Plunges Most in Five Months as Investment Talks End

Exalenz Bioscience Ltd. (EXEN) plunged the most in five months in Tel Aviv trading after the maker of breath-testing systems ended talks to receive an investment from a private fund.

Exalenz tumbled 12 percent, the biggest intraday slump since Nov. 29, to 0.3520 shekel as of 3:58 p.m. in Tel Aviv, trimming its market value to 47 million shekels ($13 million).

To contact the reporter on this story: David Wainer in Tel Aviv at dwainer3@bloomberg.net

To contact the editor responsible for this story: Claudia Maedler at cmaedler@bloomberg.net

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.